Dr Reddy's Laboratories Limited and global medical technology company Integra LifeScinces
Holdings Corporation announced on Monday that they have entered into an exclusive distribution agreement under which the Hyderabad-based generic pharma major will market and distribute DuraGen
Plus and Suturable DurgaGen dural regeneration matrices for use by patients in India.
M V Ramana, executive vice-president and head of emerging markets and India business at Dr Reddy's, said, "We are delighted to partner with Integra LifeSciences. With the launch of DuraGen, we look forward to building our presence in the segment of regenerative technologies and making a difference to the lives of patients undergoing neurosurgery.
Commenting on the tie-up, Integra LifeSciences Chief Financial Officer Glenn Coleman stated that this collaboration will allow the company to expand patient access globally and provide innovative regenerative technology solutions to neurosurgeons and patients in India.
The DurgaGen product line offers 'Duraplasty Solutions' meant for the repair of the dura mater. The dura mater is a thick membrane that surrounds the brain and spinal cord and contains the cerebrospinal fluid.
Plus Dural Regeneration Matrix is indicated as a dural substitute for the repair of dura mater, according to the company. Integra manufactures the DuraGen
family of products based on its proprietary Ultra Pure Collagen technology platform.